欧盟传统药品法于五月底正式生效,其放宽了植物药市场准入条件,首度承认符合条件的中药可获得药品的合法“身份”。 据了解,与两年前《指令(草案)》的内容相比,该指令大幅降低了植物药市场准入条件。此举意味着欧盟对中药进口的政策出现了重 The EU’s traditional drug law came into effect at the end of May. It relaxed the market access conditions for botanicals and, for the first time, recognized the legal “identities” of eligible Chinese medicines. It is understood that, compared with the content of the “Directive (Draft)” two years ago, this directive has greatly reduced the market access conditions for plant drugs. This move implied that the EU’s policy on the import of Chinese medicine